CVS HEALTH Corp CVS
Price
Full chart with drawing tools and indicators
Valuation and ratios (P/E, margins, market value)
Price charts and figures by TradingView, shown in a sealed box: it cannot read this page, but TradingView may count your visit. Prices can be delayed.
Results from SEC filings
| Revenue | $402.1B | +8% | FY ending Dec 31, 2025 |
|---|---|---|---|
| Gross profit | $28.5B | -1% | FY ending Dec 31, 2017 |
| Operating income | $4.7B | -45% | FY ending Dec 31, 2025 |
| Net income | $1.8B | -62% | FY ending Dec 31, 2025 |
| Earnings per share | $1.39 | -62% | FY ending Dec 31, 2025 |
| Cash from operations | $10.6B | +17% | FY ending Dec 31, 2025 |
| Capital spending | $2.8B | +2% | FY ending Dec 31, 2025 |
| Share buybacks | $0 | -100% | FY ending Dec 31, 2025 |
| Dividends paid | $3.4B | +1% | FY ending Dec 31, 2025 |
| Cash | $8.5B | -2% | FY ending Dec 31, 2025 |
| Long-term debt | $71.3B | -0% | FY ending Jan 1, 2019 |
| Shareholders' equity | $75.2B | -0% | FY ending Dec 31, 2025 |
| Shares outstanding | 1.27B | +1% | FY ending Dec 31, 2025 |
Insider trades
Last 12 months: 1 open-market buy ($1,289) and 4 sales ($323.7M) by officers, directors and big owners. These are exact: shares times the price each insider reported. Several sales by one person on one day are combined (average price).
| Insider | Trade | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Larry RobbinsDirector | Sold | 370,462 | $93.45 | $34.6M | May 21, 2026 |
| Larry RobbinsDirector | Sold4 fills | 1,018,000 | $93.82 avg | $95.5M | May 20, 2026 |
| Larry RobbinsDirector | Sold2 fills | 1,983,538 | $94.45 avg | $187.3M | May 19, 2026 |
| Tilak MandadiEVP, Chief Exp & Tech Officer | Sold | 69,551 | $89.58 | $6.2M | May 8, 2026 |
| Steven H NelsonEVP and President, Aetna | Bought | 24 | $53.70 | $1,289 | Jan 23, 2025 |
Other insider moves (43): pay awards, option exercises, tax withholding, gifts
| Insider | Trade | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| James David ClarkSVP, Cont & Chief Acct Officer | Tax withholding | 454 | $90.98 | $41K | Jun 26, 2026 |
| Amy Compton-PhillipsEVP, Chief Medical Officer | Tax withholding | 7,618 | $90.98 | $693K | May 31, 2026 |
| Brian NewmanEVP, Chief Financial Officer | Tax withholding | 2,478 | $90.98 | $225K | May 31, 2026 |
| Fernando AguirreDirector | Returned | 1,563 | $93.50 | $146K | May 21, 2026 |
| Fernando AguirreDirector | Returned | 30,437 | $93.78 | $2.9M | May 20, 2026 |
| Jeffrey R. BalserDirector | Award | 2,058 | $97.15 | $200K | May 14, 2026 |
| Fernando AguirreDirector | Award | 1,563 | $97.15 | $152K | May 14, 2026 |
| C David Ii BrownDirector | Award | 1,544 | $97.15 | $150K | May 14, 2026 |
| J Scott KirbyDirector | Award | 1,447 | $97.15 | $141K | May 14, 2026 |
| Leslie V NorwalkDirector | Award | 1,447 | $97.15 | $141K | May 14, 2026 |
| Guy P SansoneDirector | Award | 1,447 | $97.15 | $141K | May 14, 2026 |
| J. David JoynerPresident, CEO and Chair, Director | Tax withholding | 8,029 | $72.49 | $582K | Apr 1, 2026 |
| Tilak MandadiEVP, Chief Exp & Tech Officer | Tax withholding | 3,634 | $72.49 | $263K | Apr 1, 2026 |
| Samrat S. KhichiEVP, CPO and General Counsel | Tax withholding | 3,541 | $72.49 | $257K | Apr 1, 2026 |
| James David ClarkSVP, Cont & Chief Acct Officer | Tax withholding | 3,262 | $72.49 | $236K | Apr 1, 2026 |
| Steven H NelsonEVP and President, Aetna | Tax withholding | 2,432 | $72.49 | $176K | Apr 1, 2026 |
| Prem S ShahEVP and Group President | Tax withholding | 1,484 | $72.49 | $108K | Apr 1, 2026 |
| Heidi B CapozziEVP and Chief People Officer | Tax withholding | 1,334 | $72.49 | $97K | Apr 1, 2026 |
| J. David JoynerPresident, CEO and Chair, Director | Award | 86,326 | $71.82 | $6.2M | Mar 31, 2026 |
| Prem S ShahEVP and Group President | Award | 25,062 | $71.82 | $1.8M | Mar 31, 2026 |
| Steven H NelsonEVP and President, Aetna | Award | 22,277 | $71.82 | $1.6M | Mar 31, 2026 |
| Tilak MandadiEVP, Chief Exp & Tech Officer | Award | 22,277 | $71.82 | $1.6M | Mar 31, 2026 |
| Brian NewmanEVP, Chief Financial Officer | Award | 19,493 | $71.82 | $1.4M | Mar 31, 2026 |
| Samrat S. KhichiEVP, CPO and General Counsel | Award | 12,531 | $71.82 | $900K | Mar 31, 2026 |
| James David ClarkSVP, Cont & Chief Acct Officer | Award | 11,138 | $71.82 | $800K | Mar 31, 2026 |
| Heidi B CapozziEVP and Chief People Officer | Award | 10,025 | $71.82 | $720K | Mar 31, 2026 |
| Amy Compton-PhillipsEVP, Chief Medical Officer | Award | 5,569 | $71.82 | $400K | Mar 31, 2026 |
| John E GallinaDirector | Award | 582 | $71.86 | $42K | Mar 19, 2026 |
| Samrat S. KhichiEVP, CPO and General Counsel | Tax withholding | 7,886 | $79.60 | $628K | Feb 28, 2026 |
| J. David JoynerPresident and CEO, Director | Tax withholding | 1,944 | $79.90 | $155K | Feb 28, 2026 |
| Prem S ShahEVP and Group President | Tax withholding | 247 | $80.13 | $20K | Jan 1, 2026 |
| James David ClarkSVP, Cont & Chief Acct Officer | Tax withholding | 220 | $79.10 | $17K | Dec 1, 2025 |
| Roger N FarahDirector | Tax withholding | 9,748 | $80.36 | $783K | Nov 30, 2025 |
| Heidi B CapozziEVP and Chief People Officer | Tax withholding | 9,470 | $80.36 | $761K | Nov 30, 2025 |
| Tilak MandadiEVP, Chief Exp & Tech Officer | Tax withholding | 6,575 | $80.36 | $528K | Nov 30, 2025 |
| Fernando AguirreDirector | Award | 1,800 | $76.04 | $137K | Nov 20, 2025 |
| C David Ii BrownDirector | Award | 1,775 | $76.04 | $135K | Nov 20, 2025 |
| Jeffrey R. BalserDirector | Award | 1,775 | $76.04 | $135K | Nov 20, 2025 |
| Douglas H. ShulmanDirector | Award | 1,652 | $76.04 | $126K | Nov 20, 2025 |
| Guy P SansoneDirector | Award | 1,652 | $76.04 | $126K | Nov 20, 2025 |
| Leslie V NorwalkDirector | Award | 1,652 | $76.04 | $126K | Nov 20, 2025 |
| J Scott KirbyDirector | Award | 1,652 | $76.04 | $126K | Nov 20, 2025 |
| Anne A. FinucaneDirector | Award | 591 | $76.04 | $45K | Nov 20, 2025 |
Trades by members of Congress
9 members reported 4 buys and 11 sales since Oct 29, 2024. Amounts are legal ranges, not exact figures.
| Member | Trade | Amount | Traded | Reported | Owner |
|---|---|---|---|---|---|
| Dwight Evans D | Sold some | $1,001–$15K | Nov 21, 2025 | May 15, 2026175 days later | Self |
| Dwight Evans D | Sold | $1,001–$15K | Nov 21, 2025 | Dec 19, 2025 | Self |
| Lisa C. McClain R | Sold | $1,001–$15K | Oct 31, 2025 | Nov 21, 2025 | Spouse |
| Lisa C. McClain R | Sold | $1,001–$15K | Oct 30, 2025 | Nov 21, 2025 | Spouse |
| Lisa C. McClain R | Bought | $1,001–$15K | Oct 30, 2025 | Nov 21, 2025 | Spouse |
| Val T. Hoyle D | Sold | $1,001–$15K | Sep 23, 2025 | Oct 10, 2025 | Spouse |
| Val T. Hoyle D | Bought | $1,001–$15K | Oct 29, 2024 | Sep 12, 2025318 days later | Spouse |
| Adam Smith D | Sold | $1,001–$15K | Aug 8, 2025 | Aug 8, 2025 | Spouse |
| Jefferson Shreve R | Sold | $15K–$50K | May 12, 2025 | Jun 22, 2025 | Self |
| Robert P. Bresnahan, Jr. R | Sold | $1,001–$15K | May 15, 2025 | May 31, 2025 | Self |
| Julie Johnson D | Sold | $1,001–$15K | Apr 1, 2025 | May 14, 2025 | Joint |
| Robert P. Bresnahan, Jr. R | Bought | $1,001–$15K | Feb 25, 2025 | Mar 27, 2025 | Self |
| Julie Johnson D | Sold some | $1,001–$15K | Jan 15, 2025 | Feb 12, 2025 | Joint |
| Gilbert Ray Cisneros, Jr. D | Bought | $1,001–$15K | Jan 24, 2025 | Feb 11, 2025 | Self |
| J. French Hill R | Sold | $15K–$50K | Jan 31, 2025 | Feb 4, 2025 | Self |
Latest SEC filings
- News filing: Executive or board change, Public announcement (Reg FD) 8-K · Aug 17, 2026
- Quarterly report 10-Q · Aug 5, 2026
- News filing: Quarterly results 8-K · Aug 5, 2026
- Insider plans to sell 144 · May 22, 2026
- Insider plans to sell 144 · May 21, 2026
- News filing: Executive or board change, Shareholder vote results 8-K · May 18, 2026
- Insider plans to sell 144 · May 8, 2026
- Quarterly report 10-Q · May 6, 2026
- News filing: Quarterly results 8-K · May 6, 2026
- Shareholder meeting proxy DEF 14A · Apr 3, 2026
- News filing: Executive or board change 8-K · Mar 19, 2026
- Annual report 10-K · Feb 10, 2026
- News filing: Quarterly results 8-K · Feb 10, 2026
- News filing: Public announcement (Reg FD) 8-K · Dec 9, 2025
- News filing: Other news 8-K · Nov 20, 2025
- Quarterly report 10-Q · Oct 29, 2025
- News filing: Quarterly results 8-K · Oct 29, 2025
- News filing: Other news 8-K · Sep 22, 2025
- Insider plans to sell 144 · Aug 19, 2025
- News filing: Other news 8-K · Aug 15, 2025
- Quarterly report 10-Q · Jul 31, 2025
- News filing: Quarterly results 8-K · Jul 31, 2025
- News filing: Shareholder vote results 8-K · May 20, 2025
- Quarterly report 10-Q · May 1, 2025
- News filing: Quarterly results 8-K · May 1, 2025
About CVS HEALTH Corp
Business description
- Industry
- Retail-Drug Stores and Proprietary Stores
- Sector
- Trade & Services
- Headquarters
- Woonsocket, RI
- Incorporated in
- DE
- Fiscal year ends
- December 31
- Exchange
- NYSE
- Filer size
- Large accelerated filer
- Formerly
- CVS CAREMARK CORP, CVS/CAREMARK CORP, CVS CORP, MELVILLE CORP
- SEC company number (CIK)
- 64803
Company figures and insider trades: U.S. Securities and Exchange Commission (EDGAR). Congress trades: Clerk of the U.S. House of Representatives. Nebula is not affiliated with either and this page is not investment advice.